Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015015 · ClinicalTrials.gov registry record
Dichloroacetate Kinetics, Metabolism and Toxicology
A clinical trial of Lactic Acidosis, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT00015015: Completed study of Lactic Acidosis, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00015015 is a study of Lactic Acidosis that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00015015, a study of Lactic Acidosis, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Dichloroacetate (DCA) is a product of water chlorination and a metabolite of certain industrial solvents, thus making it a chemical of environmental concern. However, DCA is also used as an investigational drug for treating various diseases of adults and children, at doses far greater than those to which humans are normally exposed in the environment. Our research involves how DCA is metabolized by healthy adults and by children with a fatal genetic disease, congenital lactic acidosis (CLA) who are treated with DCA.
Conditions Studied
Interventions
- DRUG Dichloroacetate
Study Locations (1)
Florida
- Univ. of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 1994-12 |
| Est. Completion | 2002-10 |
What the finished NCT00015015 record still lists
NCT00015015 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Lactic Acidosis appearing as the primary indexed condition, and to 1 intervention - of which Dichloroacetate is the first listed.
NCT00015015 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00015015 about?
NCT00015015 is a clinical study titled "Dichloroacetate Kinetics, Metabolism and Toxicology". Dichloroacetate (DCA) is a product of water chlorination and a metabolite of certain industrial solvents, thus making it a chemical of environmental concern. However, DCA is also used as an investigational drug for treating various diseases of adults and children, at doses far greater than those to ...
What is the current status of trial NCT00015015?
This trial is currently completed. The enrollment target is 100 participants. The study started on 1994-12. Estimated completion is 2002-10.
What conditions does trial NCT00015015 study?
This clinical trial studies the following conditions: Lactic Acidosis.
What interventions are being tested in trial NCT00015015?
The interventions under investigation include: Dichloroacetate (DRUG).
Who is sponsoring clinical trial NCT00015015?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015015 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia